CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma.

about

CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma.

Item

http://www.wikidata.org/entity/Q55248430

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

CD47 as a potential prognostic ...... oral squamous cell carcinoma.

@en

CD47 as a potential prognostic ...... oral squamous cell carcinoma.

@nl

type

Item

label

CD47 as a potential prognostic ...... oral squamous cell carcinoma.

@en

CD47 as a potential prognostic ...... oral squamous cell carcinoma.

@nl

prefLabel

CD47 as a potential prognostic ...... oral squamous cell carcinoma.

@en

CD47 as a potential prognostic ...... oral squamous cell carcinoma.

@nl

P1476

CD47 as a potential prognostic ...... d oral squamous cell carcinoma

@en

P2093

Gang Zhou

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Rui Lu

http://www.w3.org/2001/XMLSchema#string

Xiaojing Ye

http://www.w3.org/2001/XMLSchema#string

Xiaojun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications

Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management.

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma

CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy

Exciting new advances in oral cancer diagnosis: avenues to early detection.

P304

9075-9080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8520

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

X Chen

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29805639

http://www.w3.org/2001/XMLSchema#string

P932

5958773

http://www.w3.org/2001/XMLSchema#string